Ausgabe 2/1999
Inhalt (9 Artikel)
G1‐S transition defects occur in most breast cancers and predict outcome
Niels Hilmer Nielsen, Martin Lodén, Jenny Cajander, Stefan O. Emdin, Göran Landberg
Postoperative chemo–endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor–positive stage II breast cancer
Keizo Sugimachi, Yoshihiko Maehara, Kohei Akazawa, Yasuo Nomura, Kazuyuki Eida, Michio Ogawa, Eiji Konaga, Noriaki Tanaka, Tetsuya Toge, Kiyohiko Dohi, Shoichihi Noda, Masazumi Maeda, Yasumasa Monden
Three new active cisplatin‐containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial
Giorgio Cocconi, Giancarlo Bisagni, Guido Ceci, Beatrice Di Blasio, Vincenzo De Lisi, Rodolfo Passalacqua, Alvise Zadro, Corrado Boni, Paolo Morandi, Luisa Savoldi
Meta‐analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
S. Pyrhönen, J. Ellmén, J. Vuorinen, M. Gershanovich, T. Tominaga, M. Kaufmann, D.F. Hayes
Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade
Walter Tschugguel, Christian Schneeberger, Gertrud Unfried, Klaus Czerwenka, Wolfgang Weninger, Michael Mildner, Doris M. Gruber, Michael O. Sator, Thomas Waldhör, Johannes C. Huber
Overexpression of basic fibroblast growth factor (FGF–2) downregulates Bcl–2 and promotes apoptosis in MCF–7 human breast cancer cells
Paul Maloof, Qin Wang, Huisheng Wang, Dana Stein, Thomas N. Denny, Joachim Yahalom, Eyal Fenig, Robert Wieder
Immunohistochemical labelling for prostate–specific antigen in breast carcinomas
Kalle A. Alanen, Teijo Kuopio, Yrjö U. Collan, Pauliina Kronqvist, Laura Juntti, Timo J. Nevalainen
PACAP (6–38) is a PACAP receptor antagonist for breast cancer cells
Julius Leyton, Yehoshua Gozes, Joseph Pisegna, David Coy, Sally Purdom, Marchessini Casibang, Farah Zia, Terry W. Moody
Hsp27 overexpression inhibits doxorubicin–induced apoptosis in human breast cancer cells
Rhonda K. Hansen, Irma Parra, Pierre Lemieux, Steffi Oesterreich, Susan G. Hilsenbeck, Suzanne A. W. Fuqua